Accessibility Menu
American Bio Medica Stock Quote

American Bio Medica (OTC: ABMC)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
N/A
Daily Change
N/A
Day's Range
N/A
Previous Close
N/A
Open
N/A
Beta
N/A
Volume
N/A
Average Volume
N/A
Market Cap
N/A
Market Cap / Employee
N/A
52wk Range
N/A
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

American Bio Medica Company Info

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The firm's products include Rapid Drug Screen, Rapid ONE, RDS InCup, Rapid TOX, Rapid TOX Cup II, and OralStat. Its products are related to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz on April 2, 1986 and is headquartered in Kinderhook, NY.

News & Analysis

No results found

No news articles found for American Bio Medica.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.